For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Myelodysplastic Syndromes and Myeloproliferative Neoplasms Services — Clinical Trials

Treatment Study for Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Guadecitabine versus treatment choice in adults with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML) previously treated with hypomethylating agents.

Treatment Study for Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase II part 2 expansion of oral rigosertib in combination with azacitidine in patients with myelodysplastic syndrome or acute myeloid leukemia.